Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by University of Pittsburgh
Prometheus Laboratories
Information provided by (Responsible Party):
University of Pittsburgh Identifier:
First received: February 29, 2012
Last updated: October 2, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)